Sign in

    Paige ChamberlainWolfe Research, LLC

    Paige Chamberlain's questions to Nyxoah SA (NYXH) leadership

    Paige Chamberlain's questions to Nyxoah SA (NYXH) leadership • Q4 2024

    Question

    Paige Chamberlain, on for Mike Polark, questioned why Nyxoah is confident the Genio system fits under CPT code 64568, given the code's description includes a 'pulse generator'. She also asked about the new deferred revenue policy, specifically what portion of revenue will be deferred and if recognition depends on patient compliance.

    Answer

    CEO Olivier Taelman clarified that Genio does have a pulse generator, but it is external, which fits the code's description. CFO John Landry explained that a 'small percentage' of the selling price will be deferred and recognized as disposable patches are shipped, explicitly stating that recognition is not tied to patient compliance metrics.

    Ask Fintool Equity Research AI